We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Whittaker, A, Anson, M, Harky, A.Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142:14–22.CrossRefGoogle ScholarPubMed
2
Chow, CCN, Magnussen, J, Ip, J, Su, Y.Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. [Internet]. 2020;13:e236720.CrossRefGoogle ScholarPubMed
3
Munz, M, Wessendorf, S, Koretsis, G, et al.Acute transverse myelitis after COVID-19 pneumonia. J Neurol. 2020;267:2196–7.CrossRefGoogle ScholarPubMed
Huang, HY, Shah, LM, McNally, JS, et al.COVID-19-associated myelitis involving the dorsal and lateral white matter tracts: a case series and review of the literature. AJNR Am J Neuroradiol. 2021;42:1912–7.CrossRefGoogle ScholarPubMed
6
Flanagan, EP, McKeon, A, Lennon, VA, et al.Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology. 2011;76:2089–95.CrossRefGoogle ScholarPubMed